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TECHNICAL NOTE /Cardiovascular
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Patients  with  peripheral  arterial  disease  (PAD)  are  at  increased  risk  for  acute  limb  ischemia
(ALI)  predominantly  arising  from  thromboembolic  disease  in  atherosclerotic  plaques,
bypass  grafts  (60%)  or  emboli  from  a  proximal  source  (30%)  [1,2].  Endovascular  and  open
surgical  approaches  are  available  for  managing  acute  thrombotic  events  in  ALI.  Minimally
invasive  intra-arterial  catheter-directed  thrombolysis  in  selected  patients  demonstrates
similar  success  rates  to  those  of  surgery  [3]. However,  pharmacologic  thrombolysis  in  gen-
eral  carries  a  risk  of  embolization  of  micro-debris  to  distal  sites.  Overall,  the  risk  of  distal
embolization  in  endovascular  procedures  of  the  superﬁcial  femoral  artery  (SFA)  is  around
10%  [4].  The  use  of  embolic  protection  devices  (EPD)  results  in  up  to  70%  reduction  in
microembolic  events  in  carotid  artery  interventions  [5].  By  contrast,  catheter-directed
thrombolysis  with  concomitant  use  of  EPDs  has  not  been  previously  reported  in  lower
extremity  arteries.
We  present  four  patients  with  ALI  in  whom  EPD  was  used  during  intra-arterial  throm-
bolytic  infusion  leading  to  reduced  lytic  time  and  pain  while  preserving  distal  runoff
vessels.
∗ Corresponding author at: Massachusetts General Hospital, Harvard Medical School, 55, Fruit Street, Boston, MA 02114, USA.
E-mail address: zirani@mgh.harvard.edu (Z. Irani).
http://dx.doi.org/10.1016/j.diii.2015.11.011
2211-5684/© 2015 Éditions franc¸aises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
2T
I
I
r
t
b
(
c
h
c
t
s
F
w
v
d
s
t
U
(
a
a
i
c
t
h
s
a
t
w
t
F
(
t
a
p
e
s
1
s
A
a
t
a
n
p
(
t
A
t
D
T
A
n
a
t
t
s
c
b
during  thrombolysis  administration  seems  intuitive,  further
analysis  of  its  use  in  this  setting  is  needed  to  substantiate74  
echnique and results
n  this  Institutional  Review  Board  approved  and  Health
nsurance  Portability  and  Accountability  Act  compliant  ret-
ospective  study,  four  patients  were  identiﬁed  between  2010
o  2014  using  the  search  terms  acute  limb  ischemia,  throm-
olysis  and  embolic  protection  device.  There  were  4  men
mean  age,  58.5  years;  range:  47—80)  with  signiﬁcant  vas-
ular  disease  including  past  medical  history  of  diabetes,
ypertension  and  hyperlipidemia.  Brieﬂy,  a  5-F  diagnostic
atheter  was  used  to  deﬁne  the  occluded  arterial  segment  of
he  symptomatic  lower  extremity.  To  traverse  this  occluded
egment,  an  angled  hydrophilic  wire  was  used  with  a  5-
 angled  catheter;  digital  subtraction  angiography  (DSA)
as  then  performed  initially  to  deﬁne  the  baseline  runoff
essels  to  the  foot.  Subsequently,  an  EPD  (SpideRX®,  Covi-
ien,  Mansﬁeld,  MA)  was  deployed  into  the  distal  patent
egment  of  the  vessel;  approximately,  1—3  inches  beyond
he  distal  point  of  the  occlusion  in  the  femoral  artery.
sing  the  EPD  wire,  a  5-F  multi-side  hole  infusion  catheter
Cragg-McNamara  valved  infusion  catheter®,  Covidien)  was
dvanced  into  the  occluded  segment.  Tissue  plasminogen
ctivator  (tPA;  Alteplase®,  Genetech,  San  Francisco,  CA)  was
nfused  at  a  rate  of  1  mg/hour  following  standard  proto-
ols.  The  total  tPA  infusion  time  and  analgesia  used  during
hrombolysis  were  recorded.
Three  patients  had  left  lower  limb  involvement  and  one
ad  right  lower  limb  involvement.  The  below  knee  arterial
upply  to  the  foot  was  via  posterior  tibial  artery  in  one,
nterior  tibial  in  another  and  all  three  vessels  in  the  other
wo  patients.  According  to  the  TASC  2  document,  all  patients
ere  ALI  Class  2,  with  sensory  but  no  motor  deﬁcits  at  the
ime  of  presentation.  After  evaluation  by  a  vascular  surgeon,
igure 1. A 60-year-old man with one day duration of acute limb isch
SFA) (arrow) revealed a 10 cm in-stent thrombotic occlusion. b: the embo
o the occluded segment of the SFA. c and d: following overnight thromb
rteriogram demonstrated patent SFA and runoff vessels. The embolic p
t
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atients  were  deemed  to  not  need  emergent  surgical
mbolectomy  and  were  referred  for  tPA  thrombolysis.
All  four  patients  had  a  thrombotic  occlusion  of  their  SFA
tent.  The  mean  length  of  arterial  occlusion  in  the  SFA  was
0.75  cm  (range:  8—15  cm).  The  mean  duration  of  tPA  infu-
ion  for  thrombolysis  was  19.5  hours  (range:  17—21  hours).
ll  patients  received  500  units/hour  of  heparin  IV  to  prevent
ny  pericatheter  thrombus  and  thrombus  formation  around
he  EPD.  Three  patients  did  not  require  patient-controlled
nalgesia  and  analgesia  as  needed  dose  administration  was
ot  utilized  at  the  prescribed  time  intervals.  Patients’  mean
ain  scores  using  numeric  pain  scale  during  infusion  were  4
range:  3—8).  All  interventions  were  considered  successful;
here  was  no  distal  embolization  in  any  of  the  4  patients.
t  3-week  outpatient  review,  all  four  patients  were  asymp-
omatic  and  mobile.
iscussion
his  technique  illustrates  the  potential  value  of  EPDs  in
LI  management  (Fig.  1). By  comparison  with  current  tech-
iques,  there  appeared  to  be  beneﬁt  in  both  subjective
nd  objective  parameters  in  our  patients,  with  preserva-
ion  of  distal  runoff  arteries  in  all  instances.  Not  only  did
his  eliminate  the  potential  need  for  ongoing  tPA  infu-
ion  in  these  four  patients,  it  also  potentially  reduced  the
omplications  associated  with  prolonged  tPA  use  such  as
leeding  complications.  Although  pairing  the  use  of  EPDsemia. a: arteriogram from the proximal superﬁcial femoral artery
lic protection device (arrow) was deployed a few centimeters distal
olysis with 1 mg of tissue plasminogen activator (tPA), subsequent
rotection device contained thrombotic debris (not shown).
he  potential  advantages  in  catheter-based  thrombolysis  in
LI.
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